We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Senate was urged Thursday to permanently reauthorize the Creating Hope Act, which would provide market incentives to pharmaceutical companies to develop drugs for pediatric rare diseases, ahead of a March 9 markup of the bill by the Senate HELP Committee. Read More
A year after announcing his Precision Medicine Initiative, President Barack Obama has outlined progress on the project, which aims to accelerate personalized medicine. Read More
Organizations conducting clinical trials will no longer have to submit routine GCP compliance reports that have been used to establish inspections with the UK’s Medicines and Healthcare products Regulatory Agency. Read More
The FDA has accepted Sanofi’s application for expedited review of its once-daily, fixed-dose combination of insulin glargine and GLP-1 receptor agonist lixisenatide for Type 2 diabetes. Read More